Prurigo nodularis Trials in Graz, Austria
Conditions / Prurigo nodularis / Graz, Austria
Prurigo nodularis has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04204616 | A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06516952 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) | RECRUITING | PHASE3 |
| NCT06527404 | A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03677401 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | COMPLETED | PHASE3 |
| NCT03816891 | Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis | COMPLETED | PHASE2 |
| NCT05052983 | A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis | COMPLETED | PHASE3 |
| NCT03540160 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | TERMINATED | PHASE3 |
| NCT04501666 | Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | COMPLETED | PHASE3 |
| NCT03497975 | PRISM Study-Pruritus Relief Through Itch Scratch Modulation | COMPLETED | PHASE2/PHASE3 |
| NCT05764161 | A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) | COMPLETED | PHASE3 |